Visser F - Search Results

1

Thoughts of patients with advanced heart failure on dying.

Willems DL, Hak A, Visser F, Van der Wal G. Willems DL, et al. Among authors: visser f. Palliat Med. 2004 Sep;18(6):564-72. doi: 10.1191/0269216304pm919oa. Palliat Med. 2004. PMID: 15453628

2

Patient work in end-stage heart failure: a prospective longitudinal multiple case study.

Willems DL, Hak A, Visser FC, Cornel J, van der Wal G. Willems DL, et al. Among authors: visser fc. Palliat Med. 2006 Jan;20(1):25-33. doi: 10.1191/0269216306pm1095oa. Palliat Med. 2006. PMID: 16482755

3

A qualitative validation of the Minnesota Living with Heart Failure Questionnaire.

Hak T, Willems D, van der Wal G, Visser F. Hak T, et al. Among authors: visser f. Qual Life Res. 2004 Mar;13(2):417-26. doi: 10.1023/B:QURE.0000018487.35591.6e. Qual Life Res. 2004. PMID: 15085914

4

Ejection fraction improvement by beta-blocker treatment in patients with heart failure: an analysis of studies published in the literature.

van Campen LC, Visser FC, Visser CA. van Campen LC, et al. Among authors: visser fc, visser ca. J Cardiovasc Pharmacol. 1998;32 Suppl 1:S31-5. doi: 10.1097/00005344-199800003-00006. J Cardiovasc Pharmacol. 1998. PMID: 9731693 Review.

5

Current controversies with ACE inhibitor treatment in heart failure.

Visser FC, Visser CA. Visser FC, et al. Among authors: visser ca. Cardiology. 1996;87 Suppl 1:23-8. doi: 10.1159/000177164. Cardiology. 1996. PMID: 8681318 Review.

6

Congestive heart failure: pathophysiology and management with special reference to systemic hypertension.

Visser FC. Visser FC. J Cardiovasc Pharmacol. 1991;18 Suppl 4:S8-11. J Cardiovasc Pharmacol. 1991. PMID: 1721986 Review.

7

Maximum rate of oxygen consumption related to succinate dehydrogenase activity in skeletal muscle fibres of chronic heart failure patients and controls.

Bekedam MA, van Beek-Harmsen BJ, Boonstra A, van Mechelen W, Visser FC, van der Laarse WJ. Bekedam MA, et al. Clin Physiol Funct Imaging. 2003 Nov;23(6):337-43. doi: 10.1046/j.1475-0961.2003.00517.x. Clin Physiol Funct Imaging. 2003. PMID: 14617264 Clinical Trial.

8

Sarcoplasmic reticulum ATPase activity in type I and II skeletal muscle fibres of chronic heart failure patients.

Bekedam MA, van Beek-Harmsen BJ, van Mechelen W, Boonstra A, Visser FC, van der Laarse WJ. Bekedam MA, et al. Int J Cardiol. 2009 Apr 3;133(2):185-90. doi: 10.1016/j.ijcard.2007.12.025. Epub 2008 Feb 14. Int J Cardiol. 2009. PMID: 18279980

9

Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation.

van Campen CM, Visser FC, de Cock CC, Vos HS, Kamp O, Visser CA. van Campen CM, et al. Among authors: visser fc, visser ca. Heart. 2006 Dec;92(12):1795-800. doi: 10.1136/hrt.2004.050435. Epub 2006 Jun 27. Heart. 2006. PMID: 16803940 Free PMC article.

10

Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure.

Szentesi P, Bekedam MA, van Beek-Harmsen BJ, van der Laarse WJ, Zaremba R, Boonstra A, Visser FC, Stienen GJ. Szentesi P, et al. Among authors: visser fc. J Appl Physiol (1985). 2005 Dec;99(6):2189-95. doi: 10.1152/japplphysiol.00542.2005. Epub 2005 Jul 28. J Appl Physiol (1985). 2005. PMID: 16051711 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters